Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Aranday Cortes, Elihu ^a   Kaveh, Daryan ^a   Nunez Garcia, Javier ^a   Hogarth, Philip J ^a   Vordermeier, Martin H ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSIGNATURE; BOVINE TUBERCULOSIS; CONNECTIVE TISSUE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; LUNG; MICROARRAY ANALYSIS; MOUSE; NEUTROPHIL; NONHUMAN; ORGANOGENESIS; PREDICTION; SPLEEN; TH17 CELL; UPREGULATION;

ANIMALS; BCG VACCINE; FEMALE; GENE EXPRESSION PROFILING; LUNG; MICE; MICE, INBRED BALB C; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; MUS; MYCOBACTERIUM BOVIS BCG;

EID: 77956220982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011319     Document Type: Article

References (50)

1. Vordermeier HM, Chambers MA, Buddle BM, Pollock JM, Hewinson RG (2006) Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. Vet J 171: 229-244.
2. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47.
3. Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, et al. (2009) Genomic and molecular profiling predicts response to temozolomide in melanoma. Clin Cancer Res 15: 502-510.
4. Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, et al. (2008) Immune Response to Mycobacterium tuberculosis and Identification of Molecular Markers of Disease. Am J Respir Cell Mol Biol.
5. Gaucher D, Therrien R, Kettaf N, Angermann BR, Boucher G, et al. (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205: 3119-3131.
6. Skinner MA, Wedlock DN, Buddle BM (2001) Vaccination of animals against Mycobacterium bovis. Rev Sci Tech 20: 112-132.
7. Hogarth PJ, Logan KE, Vordermeier HM, Singh M, Hewinson RG, et al. (2005) Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c-a member of the esat-6 gene family. Vaccine 23: 2557-2564.
8. Logan KE, Gavier-Widen D, Hewinson RG, Hogarth PJ (2008) Development of a Mycobacterium bovis intranasal challenge model in mice. Tuberculosis (Edinb) 88: 437-443.
9. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
10. Runza VL, Schwaeble W, Mannel DN (2008) Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 213: 297-306.
11. Lim J, Derrick SC, Kolibab K, Yang AL, Porcelli S, et al. (2009) Early pulmonary cytokine and chemokine responses in mice immunized with three different vaccines against Mycobacterium tuberculosis determined by PCR array. Clin Vaccine Immunol 16: 122-126.
12. Rodgers A, Whitmore KM, Walker KB (2006) Potential correlates of BCG induced protection against tuberculosis detected in a mouse aerosol model using gene expression profiling. Tuberculosis (Edinb) 86: 255-262.
13. Mollenkopf HJ, Hahnke K, Kaufmann SH (2006) Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis. Microbes Infect 8: 136-144.
14. Huang D, Qiu L, Wang R, Lai X, Du G, et al. (2007) Immune gene networks of mycobacterial vaccine-elicited cellular responses and immunity. J Infect Dis 195: 55-69.
15. Irwin SM, Goodyear A, Keyser A, Christensen R, Troudt JM, et al. (2008) Immune response induced by three Mycobacterium bovis BCG substrains with diverse regions of deletion in a C57BL/6 mouse model. Clin Vaccine Immunol 15: 750-756.
16. Heuts F, Carow B, Wigzell H, Rottenberg ME (2009) Use of non-invasive bioluminescent imaging to assess mycobacterial dissemination in mice, treatment with bactericidal drugs and protective immunity. Microbes Infect 11: 1114-1121.
17. Elkington PT, O'Kane CM, Friedland JS (2005) The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 142: 12-20.
18. Manicone AM, Huizar I, McGuire JK (2009) Matrilysin (Matrix Metalloproteinase-7) regulates anti-inflammatory and antifibrotic pulmonary dendritic cells that express CD103 (alpha(E)beta(7)-integrin). Am J Pathol 175: 2319-2331.
19. Goswami S, Angkasekwinai P, Shan M, Greenlee KJ, Barranco WT, et al. (2009) Divergent functions for airway epithelial matrix metalloproteinase 7 and retinoic acid in experimental asthma. Nat Immunol 10: 496-503.
20. Chen P, McGuire JK, Hackman RC, Kim KH, Black RA, et al. (2008) Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol 172: 1256-1270.
21. Wielockx B, Libert C, Wilson C (2004) Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation? Cytokine Growth Factor Rev 15: 111-115.
22. Elkington PT, Friedland JS (2006) Matrix metalloproteinases in destructive pulmonary pathology. Thorax 61: 259-266.
23. Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, et al. (2006) Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 74: 6135-6144.
24. Izzo AA, Izzo LS, Kasimos J, Majka S (2004) A matrix metalloproteinase inhibitor promotes granuloma formation during the early phase of Mycobacterium tuberculosis pulmonary infection. Tuberculosis (Edinb) 84: 387-396.
25. Elkington PT, Nuttall RK, Boyle JJ, O'Kane CM, Horncastle DE, et al. (2005) Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med 172: 1596-1604.
26. Sheen P, O'Kane CM, Chaudhary K, Tovar M, Santillan C, et al. (2009) High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J 33: 134-141.
27. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, et al. (2010) Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327: 466-469.
28. Iozzo RV (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32: 141-174.
29. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, et al. (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361-364.
30. Bensadoun ES, Burke AK, Hogg JC, Roberts CR (1997) Proteoglycans in granulomatous lung diseases. Eur Respir J 10: 2731-2737.
31. He X, Han B, Liu M (2007) Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol 292: L1039-1049.
32. Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, et al. (2007) DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 8: 456-467.
33. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
34. Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, et al. (2010) Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol 17: 793-801.
35. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, et al. (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77: 3364-3373.
36. Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, et al. (2006) Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24: 3353-3364.
37. Borelli V, Vita F, Shankar S, Soranzo MR, Banfi E, et al. (2003) Human eosinophil peroxidase induces surface alteration, killing, and lysis of Mycobacterium tuberculosis. Infect Immun 71: 605-613.
38. Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, et al. (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113: 3235-3244.
39. Plager DA, Loegering DA, Checkel JL, Tang J, Kephart GM, et al. (2006) Major basic protein homolog (MBP2): a specific human eosinophil marker. J Immunol 177: 7340-7345.
40. Moritz E, Norcia AM, Cardone JD, Kuwano ST, Chiba AK, et al. (2009) Human neutrophil alloantigens systems. An Acad Bras Cienc 81: 559-569.
41. Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521.
42. Burster T, Macmillan H, Hou T, Boehm BO, Mellins ED, Cathepsin G: roles in antigen presentation and beyond. Mol Immunol 47: 658-665.
43. Nio J, Fujimoto W, Konno A, Kon Y, Owhashi M, et al. (2004) Cellular expression of murine Ym1 and Ym2, chitinase family proteins, as revealed by in situ hybridization and immunohistochemistry. Histochem Cell Biol 121: 473-482.
44. Ordway D, Palanisamy G, Henao-Tamayo M, Smith EE, Shanley C, et al. (2007) The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J Immunol 179: 2532-2541.
45. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, et al. (2000) Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 68: 577-583.
46. Appelberg R, Silva MT (1989) T cell-dependent chronic neutrophilia during mycobacterial infections. Clin Exp Immunol 78: 478-483.
47. Lyons MJ, Yoshimura T, McMurray DN (2002) Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis. Infect Immun 70: 5471-5478.
48. Khader SA, Cooper AM (2008) IL-23 and IL-17 in tuberculosis. Cytokine 41: 79-83.
49. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
50. Hoshino A, Nagao T, Nagi-Miura N, Ohno N, Yasuhara M, et al. (2008) MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J Autoimmun 31: 79-89.